Detailed answers about OXFORD CANCER BIOMARKERS LIMITED, including incorporation, status, business activity, and accounts information.
When was OXFORD CANCER BIOMARKERS LIMITED founded?
OXFORD CANCER BIOMARKERS LIMITED was officially incorporated on 24 May 2010 and is registered under company number SC379069. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is OXFORD CANCER BIOMARKERS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of OXFORD CANCER BIOMARKERS LIMITED?
OXFORD CANCER BIOMARKERS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does OXFORD CANCER BIOMARKERS LIMITED do?
OXFORD CANCER BIOMARKERS LIMITED operates in the following sector: 86900 - Other human health activities. This provides insight into the company's primary business activity and industry focus.
What is OXFORD CANCER BIOMARKERS LIMITED's registered address?
The registered office address of OXFORD CANCER BIOMARKERS LIMITED is C/O DOUGLAS MCDONALD CA, 2 OCTAVIA BUILDINGS, KILMACOLM, PA13 4AE. This is the official address filed with Companies House for legal and statutory correspondence.
Is OXFORD CANCER BIOMARKERS LIMITED financially stable?
The most recent accounts for OXFORD CANCER BIOMARKERS LIMITED were made up to 31 December 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 September 2026.